4 entries
  • "I worked closely with Professor for more than a decade and..."
    - Sharon Hecht
  • "A giant on whose shoulders I and my colleagues were lucky..."
  • "Ruth was an incredible scientist and an amazing..."
    - Roberto Nussenzveig
  • "RUTH, My mentor one of the person that i really admire as a..."
    - Gloria Gonzalez-Aseguinolaza
The Guest Book is expired.


The NYU Langone Health community mourns the loss of Ruth Nussenzweig, MD, PhD, research professor of pathology, and professor emerita of microbiology and pathology. For decades, Ruth was devoted to scientific research that led to the prevention, cure, and treatment of human diseases. Working for NYU Langone's malaria research program in the 1960s, in 1967 Ruth discovered that irradiated malaria-causing sporozoites could be used to protect against the disease in animal models. Ruth then worked with her husband, Dr. Victor Nussenzweig, to make groundbreaking discoveries that paved the way for the first human malaria vaccine, which was recently approved for use in Africa by the World Health Organization. Ruth has been a faculty member of NYU School of Medicine since 1965 and during her tenure held key leadership positions, including head of the Division of Parasitology in the Department of Microbiology. She also served as the first chair of the Department of Medical and Molecular Parasitology, a position she held for nearly 20 years. Dr. Nussenzweig has the distinction of being the first woman to chair a department at NYU School of Medicine. The author of more than 200 peer- reviewed publications, she served on the editorial boards of prestigious journals, including Nature and Science. Additionally, in 2006 she was elected to the Health and Medicine Division of the National Academies (formerly the Institute of Medicine), and in 2013 to the National Academy of Science. We extend our deepest condolences to her husband, Victor; their sons, Andre and Michel; their daughter, Sonia; and to the entire Nussenzweig family. Kenneth G. Langone, Chair, Board of Trustees; Robert I. Grossman, MD, Dean and CEO

Published in The New York Times on Apr. 4, 2018